Benitec Biopharma (BNTC) Misses Q2 EPS by 264c
Tweet
Share
E-mailGet Alerts BNTC Hot Sheet
Join SI Premium – FREE
Benitec Biopharma (NASDAQ: BNTC) reported Q2 EPS of ($2.64).
For earnings history and earnings-related data on Benitec Biopharma (BNTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- Morgan Stanley raises dividend 15% and approves $20B buyback program
- Qualcomm expects $40bn in non-handset revenue by fiscal 2029
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
